Purchase Order HHSN272201200440P
Award Date 5/10/12
Potential Completion Date 6/8/12
Potential Value $150K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27705, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Duke University by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the National Institutes of Health (NIH). The contract, valued at $10,236,804.91, is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract does not have a set-aside designation. The contract is described as "TAS::75 0885::TAS", which likely refers to the task or service area, though the specific details are not provided. The...
- This federal contract award, valued at $13,243,407.79, was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Duke University's Office of Research Administration Division. The contract, titled "TAS::75 0885::TAS MODELING IMMUNITY FOR BIODEFENSE," is a Definitive Contract with a Cost No Fee pricing type. It has an ultimate completion date of September 29, 2015 and was initially awarded on September 30, 2010....
- This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Duke University, a private non-profit research institution, for a Phase 1 Clinical Trial Unit for Therapeutics Against Infectious Diseases. The $106,491.59 delivery order contract has an ultimate completion date of December 14, 2020 and does not have a set-aside designation. This award is part of a larger master Indefinite Delivery Vehicle (IDV) contract focused on...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, awarded a $19,829,599.29 definitive cost-no-fee contract to Duke University for a Nonhuman Primate Core Humoral Immunology Laboratory to support AIDS vaccine research and development. The contract has a period of performance through March 29, 2025 and does not have a set-aside designation. Duke University's Office of Research Administration Division is the prime contractor for this award, which appears to be...
- This is a $2,361,452.65 federal contract award to Duke University, a private non-profit university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is for a Phase 1 Clinical Trial Unit to develop therapeutics against infectious diseases. It is a delivery order placed under the Therapeutics Against Infectious Diseases Phase 1 indefinite delivery, indefinite quantity (IDIQ) contract. The contract has no...
- This is a $6,178,859.14 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Duke University. The contract is for a "NONHUMAN PRIMATE CORE VIROLOGY LABORATORY FOR AIDS VACCINE RESEARCH AND DEVELOPMENT". This is a definitive, cost-no-fee contract with a period of performance through December 14, 2024. The contract was awarded on December 22, 2017 and does not have a set-aside...
- This is a $7,839,205 federal contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Duke University. The contract supports research related to the discovery and validation of novel human B cell epitopes that elicit antibodies associated with infectious agents, autoimmune diseases, allergic conditions, and transplant rejection/tolerance. The contract is a definitive, cost-no-fee contract with a period of...
- The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, has awarded a $21,659,151.36 definitive cost-no-fee contract to Duke University to support the "ADVANCED DEVELOPMENT OF A NEUTRALIZING ANTIBODY VACCINE FOR PANDEMIC AND PRE-EMERGENT CORONAVIRUSES." This contract, which does not have a set-aside designation, will run through September 18, 2026. Duke University's Office of Research Administration Division will serve as the prime contractor on this...
- This is a federal contract award to Duke University, a private university, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract is part of the Vaccine and Treatment Evaluation Units (VTEU) program, which supports clinical research on vaccines and treatments for infectious diseases. The specific award is for Task B1C1 under contract HHSN272201300017I, with a ceiling value of $1,154,053.22. The award date was...
- This is a federal contract award to Duke University, a private university and non-profit organization, by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH) under the U.S. Department of Health and Human Services (HHS). The contract is a Delivery Order under the "Therapeutics Against Infectious Diseases Phase 1" indefinite delivery/indefinite quantity (IDIQ) contract vehicle, with a ceiling value of $212,814.70....